Differential Safety Between Top-Ranked Cancer Hospitals and Their Affiliates for Complex Cancer Surgery.
Aged
Aged, 80 and over
Cancer Care Facilities
/ classification
Cross-Sectional Studies
Decision Making
Female
Hospitals
/ classification
Humans
Male
Medicare
Neoplasms
/ surgery
Observational Studies as Topic
Perioperative Period
/ mortality
Safety-net Providers
/ trends
United States
/ epidemiology
Journal
JAMA network open
ISSN: 2574-3805
Titre abrégé: JAMA Netw Open
Pays: United States
ID NLM: 101729235
Informations de publication
Date de publication:
05 04 2019
05 04 2019
Historique:
entrez:
13
4
2019
pubmed:
13
4
2019
medline:
23
2
2020
Statut:
epublish
Résumé
Leading cancer hospitals have increasingly shared their brands with other hospitals through growing networks of affiliations. However, the brand of top-ranked cancer hospitals may evoke distinct reputations for safety and quality that do not extend to all hospitals within these networks. To assess perioperative mortality of Medicare beneficiaries after complex cancer surgery across hospitals participating in networks with top-ranked cancer hospitals. A cross-sectional study was performed of the Centers for Medicare & Medicaid Services 100% Medicare Provider and Analysis Review file from January 1, 2013, to December 31, 2016, for top-ranked cancer hospitals (as assessed by U.S. News and World Report) and affiliated hospitals that share their brand. Participants were 29 228 Medicare beneficiaries older than 65 years who underwent complex cancer surgery (lobectomy, esophagectomy, gastrectomy, colectomy, and pancreaticoduodenectomy [Whipple procedure]) between January 1, 2013, and October 1, 2016. Undergoing complex cancer surgery at a top-ranked cancer hospital vs an affiliated hospital. Risk-adjusted 90-day mortality estimated using hierarchical logistic regression and comparison of the relative safety of hospitals within each cancer network estimated using standardized mortality ratios. A total of 17 300 patients (59.2%; 8612 women and 8688 men; mean [SD] age, 74.7 [6.2] years) underwent complex cancer surgery at 59 top-ranked hospitals and 11 928 patients (40.8%; 6287 women and 5641 men; mean [SD] age, 76.2 [6.9] years) underwent complex cancer surgery at 343 affiliated hospitals. Overall, surgery performed at affiliated hospitals was associated with higher 90-day mortality (odds ratio, 1.40; 95% CI, 1.23-1.59; P < .001), with odds ratios that ranged from 1.32 (95% CI, 1.12-1.56; P = .001) for colectomy to 2.04 (95% CI, 1.41-2.95; P < .001) for gastrectomy. When the relative safety of each top-ranked cancer hospital was compared with its collective affiliates, the top-ranked hospital was safer than the affiliates in 41 of 49 studied networks (83.7%; 95% CI, 73.1%-93.3%). The likelihood of surviving complex cancer surgery appears to be greater at top-ranked cancer hospitals compared with the affiliated hospitals that share their brand. Further investigation of performance across trusted cancer networks could enhance informed decision making for complex cancer care.
Identifiants
pubmed: 30977848
pii: 2730471
doi: 10.1001/jamanetworkopen.2019.1912
pmc: PMC6481444
doi:
Types de publication
Comparative Study
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e191912Subventions
Organisme : NCATS NIH HHS
ID : UL1 TR001863
Pays : United States
Commentaires et corrections
Type : CommentIn
Type : ErratumIn
Références
Med Care. 2004 Apr;42(4):355-60
pubmed: 15076812
Am J Med Qual. 2017 Nov/Dec;32(6):632-637
pubmed: 28693335
N Engl J Med. 2010 Mar 25;362(12):1110-8
pubmed: 20335587
World J Surg. 2011 Sep;35(9):1950-6
pubmed: 21732207
Ann Surg. 2007 May;245(5):777-83
pubmed: 17457171
N Engl J Med. 2011 Jun 2;364(22):2128-37
pubmed: 21631325
Am J Surg. 2018 Jan;215(1):66-70
pubmed: 28599835
JAMA. 2013 Nov 13;310(18):1964-70
pubmed: 24219952
Ann Surg Oncol. 2006 Jun;13(6):851-8
pubmed: 16614875
N Engl J Med. 2003 Nov 27;349(22):2117-27
pubmed: 14645640
JAMA. 1998 Nov 25;280(20):1747-51
pubmed: 9842949
J Clin Oncol. 2015 Feb 10;33(5):455-64
pubmed: 25547502
Surgery. 2012 Feb;151(2):171-82
pubmed: 21975292
N Engl J Med. 2002 Apr 11;346(15):1128-37
pubmed: 11948273
Surgery. 2004 Jun;135(6):569-75
pubmed: 15179361
Ann Surg. 2019 Aug;270(2):288-294
pubmed: 29672403
Ann Surg. 2012 Apr;255(4):703-7
pubmed: 22388108
Ann Surg Oncol. 2010 Nov;17(11):2824-31
pubmed: 20559740
JAMA Surg. 2014 Jul;149(7):631-2
pubmed: 24897945
JAMA Oncol. 2018 Jul 1;4(7):1008-1009
pubmed: 29852033
N Engl J Med. 2015 Oct 8;373(15):1388-90
pubmed: 26444728
Annu Rev Med. 2009;60:405-15
pubmed: 18759554
Ann Surg Oncol. 2019 Mar;26(3):732-738
pubmed: 30311158
Ann Surg. 2016 Feb;263(2):286-91
pubmed: 25915912
Ann Surg. 2014 Aug;260(2):244-51
pubmed: 24368634
J Thorac Dis. 2018 Mar;10(3):1721-1731
pubmed: 29707326
J Health Econ. 2009 Dec;28(6):1154-65
pubmed: 19818518
PLoS One. 2014 Sep 23;9(9):e107803
pubmed: 25247921
Ann Surg Oncol. 2014 Nov;21(12):3732-8
pubmed: 24895113
Health Serv Res. 2010 Oct;45(5 Pt 1):1148-67
pubmed: 20579125
Health Mark Q. 2014;31(1):65-77
pubmed: 24617723
JAMA Netw Open. 2018 Nov 2;1(7):e184595
pubmed: 30646367
Health Aff (Millwood). 2004;Suppl Variation:VAR45-53
pubmed: 15471773
Ann Surg. 2019 Aug;270(2):281-287
pubmed: 29697446
Med Care. 1998 Jan;36(1):8-27
pubmed: 9431328
Arch Surg. 2003 Jul;138(7):721-5; discussion 726
pubmed: 12860752
Circulation. 2006 Apr 4;113(13):1693-701
pubmed: 16549636